Strengthening the competitiveness of the clinical testing business and dispensing pharmacy business
In the clinical testing business and dispensing pharmacy business, competition is expected to intensify in the future as the markets mature and medical fees and drug prices are being reduced.
We will strive to strengthen our competitiveness by promoting area dominant development centered on metropolitan areas, reinforcing connections with customers by utilizing ICT, reforming our business structure so as to enable efficient and flexible response, and creating synergistic effects with new businesses.
Establishing new pillars of earnings
Taking gene-based medical care and ICT-based medical efficiency improvement as business opportunities, we aim to establish the following businesses as new pillars of earnings next to the clinical testing business and dispensing pharmacy business.
- ・ Business expansion by expanding the indications for the in-vitro diagnostic drug “MSI testing kit (FALCO)”
- ・ Strengthen sales of cloud-based electronic medical record "HAYATE / NEO"
- ・ Active expansion of clinic support business using ICT